Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE Cause Atrioventricular block first degree? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Atrioventricular block first degree have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.0% of all adverse event reports for GEMCITABINE.

7
Reports of Atrioventricular block first degree with GEMCITABINE
0.0%
of all GEMCITABINE reports
0
Deaths
5
Hospitalizations

How Dangerous Is Atrioventricular block first degree From GEMCITABINE?

Of the 7 reports, 5 (71.4%) required hospitalization, and 3 (42.9%) were considered life-threatening.

Is Atrioventricular block first degree Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE Cause?

Off label use (3,319) Disease progression (3,123) Thrombocytopenia (2,320) Drug ineffective (2,003) Malignant neoplasm progression (1,962) Neutropenia (1,892) Anaemia (1,745) Pyrexia (1,511) Nausea (1,336) Myelosuppression (1,197)

What Other Drugs Cause Atrioventricular block first degree?

FINGOLIMOD (285) AMLODIPINE (148) METOPROLOL (120) BISOPROLOL (98) FLECAINIDE (98) OMEPRAZOLE (94) AMIODARONE (85) VERAPAMIL (84) DILTIAZEM (79) FUROSEMIDE (78)

Which GEMCITABINE Alternatives Have Lower Atrioventricular block first degree Risk?

GEMCITABINE vs GEMCITABINE\GEMCITABINE GEMCITABINE vs GEMFIBROZIL GEMCITABINE vs GEMTUZUMAB OZOGAMICIN GEMCITABINE vs GEMZAR GEMCITABINE vs GENTAMICIN

Related Pages

GEMCITABINE Full Profile All Atrioventricular block first degree Reports All Drugs Causing Atrioventricular block first degree GEMCITABINE Demographics